July 22, 2022 Comments Off on New tentative approval for Eugia Pharma drug palbociclib Posted in: Tentative Approval Palbociclib is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. There are six patents protecting this compound. Drug patent litigation for PALBOCICLIB.…
The post New tentative approval for Eugia Pharma drug pal…
July 22, 2022 Comments Off on New patent for Abbvie Inc drug VENCLEXTA Posted in: Patent Added Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPate…
